Join @ipna.bsky.social and KDIGO tomorrow for a webinar on pediatric CKD, featuring key updates from the KDIGO CKD Guideline and CKD–MBD Controversies Conference—and available in 50+ languages!
🗓️ Oct 23 | 1 PM CEST / 7 AM EST
🔗 kdigo.co/IPNA-KDIGO-C...
#CKD #CKDMBD #PediatricNephrology
Proposed update to current treatment paradigm for dysregulated vitamin D metabolism in CKD ca. 2025 from @asnpublications.bsky.social
#Nephpearls #CKDMBD #NephSky
👉 pubmed.ncbi.nlm.nih.gov/40857105/
What is the target intact PTH level in patients with CKD who are not on dialysis? from @kdigo.org
#Nephpearls #CKDMBD #NephSky
👉 kdigo.org/guidelines/c...
Osteocytes burn out, give bone a break
doi.org/10.1016/j.kint.2025.03.015
Original article: doi.org/10.1016/j.kint.2025.01.022
#KICommentary #NephSky #MedSky #CKDMBD #kidney
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney Failure ca. 2025
#Nephpearls #NephSky #CKDMBD
👉🏼 pubmed.ncbi.nlm.nih.gov/38992521/
Join Conference Co-Chairs Markus Ketteler and Rosa Moysés, and Work Group Member Smeeta Sinha to learn more about the latest progress, challenges, and knowledge gaps in personalizing #CKDMBD care.
📢 Check out the final report from the KDIGO CKD-MBD Controversies Conference, published in the March issue of Kidney International! Explore key insights on osteoporosis, vascular calcification, and cardiovascular disease in CKD.
🔗 Read the report in KI: kdigo.co/2025-CKD-MBD...
#CKDMBD
Evolution of terminology for renal osteodystrophy ca. 2025 from @kdigo.org @kidneyint.bsky.social
#Nephpearls #NephSky #CKDMBD
👉 pubmed.ncbi.nlm.nih.gov/39864017/
Don't miss the @theisn.org-KDIGO Webinar: "Chronic Kidney Disease-Mineral and Bone Disorder: Progress and Knowledge Gaps Towards Personalizing CKD-MBD Care."
Thursday, March 13 at 8am ET/ 2pm CET
Register: kdigo.co/ISN-KDIGO-CK...
#CKDMBD
